Lafora's disease: Towards a clinical, pathologic, and molecular synthesis

Pediatric Neurology

Volumn 25, Issue 1, 2001, Pages 21-29

  Minassian, Berge A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE POLYMER; LAFORIN; PHOSPHATASE; PROTEIN; UNCLASSIFIED DRUG;

CHILDHOOD MORTALITY; CLINICAL FEATURE; DEMENTIA; DISEASE COURSE; GENE MUTATION; HUMAN; MYOCLONUS EPILEPSY; PATHOGENESIS; PHOTOSENSITIVE EPILEPSY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; VISUAL FIELD DEFECT; VISUAL HALLUCINATION;

ADULT; AGE OF ONSET; BRAIN; CHILD; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; GLUCANS; HUMANS; LAFORA DISEASE; MODELS, NEUROLOGICAL; MUTATION; MYOCLONIC EPILEPSIES, PROGRESSIVE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0034907260     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(00)00276-9     Document Type: Review

References (67)

1. Incidence and prevalence
2. Progressive myoclonus epilepsies in childhood and adolescence
3. The neuronal ceroid-lipofuscinoses
4. Batten's disease: Eight genes and still counting?
5. Progressive myoclonus epilepsy of Unverricht-Lundborg type
6. Mitochondrial DNA mutations and mitochondrial dysfunction in epilepsy
7. Genetics of myoclonic and myoclonus epilepsies
8. Lafora's disease
9. Progressive Myoclonus epilepsy with Lafora inclusion bodies
10. Myoclonic epilepsy with Lafora bodies
11. Studies in Myoclonus epilepsy (Lafora Body form)
12. Lafora's disease: Peroxisomal storage in skeletal muscle
13. Lafora disease, a form of progressive myoclonus epilepsy
14. Lafora disease: A quantitative morphological and biochemical study of the cerebral cortex
15. Lafora disease: Diagnosis by liver biopsy
16. Longitudinal clinicoelectrophysiologic study of a case of lafora disease proven by skin biopsy
17. Lafora disease: Liver histopathology in presymptomatic children
18. Le diagnostic precoce de la maladie de Lafora. Importance des manifestations paroxystiques visuelles et interet de la biopsie cutanee
19. Lafora's disease
20. Biopsy results in a kindred with Lafora disease
21. Progressive myoclonus epilepsies: Clinical and genetic aspects
22. Familial progressive myoclonus epilepsy: Clinical and electrophysiologic observations
23. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy
24. A case of Lafora's disease associated with cardiac arrhythmia
25. Epilepsie-myoclonie progressive avec corps de Lafora. Etude clinique et polygraphique. Controle anatomique ultra-structural
26. Photic cortical reflex myoclonus
27. Photic reflex myoclonus: A neurophysiologic study in progressive myoclonus epilepsy
28. Beitrag zur histopathologie der myoklonischen epilepsie
29. Corpora-amylacea and the family of polyglucosan diseases
30. Progressive familial myoclonic epilepsy in three families: Its clinical features and pathological basis
31. Sweat gland duct cells in Lafora disease: Diagnosis by skin biopsy
32. Axilla skin biopsy; a reliable test for the diagnosis of Lafora's disease
33. New deletion mutations in EPM2A and the genetic diagnosis of Lafora's disease
34. Studies in myoclonus epilepsy (Lafora body form); II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea
35. Studies in myoclonus epilepsy. III. The effects of amylolytic enzymes on the ultrastructure of Lafora bodies
36. Type IV glycogenosis (amylopectinosis): Light and electron microscopic observations
37. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes. A report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal aging
38. Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast
39. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene
40. Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease
41. Ultrastructural findings in Lafora disease
42. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q
43. Genetic locus heterogeneity in Lafora's progressive myoclonus epilepsy
44. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy
45. A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2)
46. The human and mouse homologues of the epilepsy gene, EPM2A: Isolation and characterization of full-length transcripts and mutation detection in Lafora disease families
47. Evolutionary conservation and differential expression of EPM2A gene
48. Mutation and polymorphism in the human EPM2 gene in Lafora disease
49. Laforin, defective in the progressive myoclonus epilepsy of lafora type, is a dual-specificity phosphatase associated with polyribosomes
50. Laforin in Lafora's progressive myoclous epilepsy: Function and subcellular localization
51. Laforin is a cell membrane and endoplasmic reticulum associated protein tyrosine phosphatase
52. From form to function: Signaling by protein tyrosine phosphatases
53. The "VH1-like" dual-specificity protein tyrosine phosphatases
54. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-triphosphate and Akt/protein kinase B signaling pathway
55. Human PIR1 of the protein-tyrosine phosphatase superfamily has RNA 5′-triphosphatase and diphosphatase activities
56. Updating the sequence-based classification of glycosyl hydrolases
57. Structure and function of proteins of the phosphotransferase system and of 6-phospho-beta-glycosidases in gram-positive bacteria
58. Specificity of the binding domain of glucoamylase 1
59. Raw-starch-digesting and thermostable α-amylase from the yeast cryptococcus sp. S-2: Purification, characterization, cloning and sequencing
60. Studies of corpora amylacea: I. Isolation and preliminary characterization by chemical and histochemical techniques
61. Monoclonal antibody against polyglucosan isolated from the myocardium of a patient with Lafora disease
62. Surprises of genetic engineering: A possible model of polyglucosan body (Lafora) disease
63. Glycogen accumulation in the nerves and kidney of chronically diabetic rats
64. Glycogen storage diseases
65. Metabotropic glutamate receptor-initiated translocation of protein kinase p90rsk to polyribosomes: A possible factor regulating synaptic protein synthesis
66. Lafora's disease: An ultrastructural and histochemical study
67. Kinases and phosphatases - A marriage is consummated